65,437 trials
Liver Fibrosis · Cirrhosis · Chronic Hepatitis B
Primary: The Clinical Value Evaluation of FibroTouch for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Hepatitis B by Using Liver Pathology as the Gold…
Urinary Incontinence · Retention, Urinary
Primary: Number of Flow-stop Episodes — 0.17; 1.09 Flow stop episodes — p=<0.05
Long COVID
Primary: Fatigue Severity Scale — -11.3; -8.6 score on a scale — p=0.46
Infections, Meningococcal
Primary: Number of Participants With Solicited Local Adverse Events (AEs) After the Vaccination With rMenB+OMV NZ — 12; 12; 14; 22 Participants
Trauma · Injuries
Primary: Consumer Assessment of Healthcare Providers and Systems Child Hospital Survey Communication Subscale — 0.769; 0.775; 0.735; 0.747 score on a scale
Nearsightedness
Primary: Mean Difference Between Predicted and Actual Central Vault at 1-month After ICL Implantation — 0.170 Milimeters
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis) · Central Retinal Vein Occlusion With Macular Edema · Exudative Age-Related Macular Degeneration, Unspecified Eye
Primary: The Efficacy of Cooled Versus Room Temperature Artificial Tears in Reducing Post Intravitreal Injection Ocular Discomfort as Measured by Pain Scale Survey. — 2.21; 1.95…
Healthy
Primary: Pharmacokinetics (PK): Maximum Concentration (Cmax) of Mirikizumab Administered by PFS and AI — 20.0; 23.5 micrograms per milliliter (μg/mL)
Atrial Fibrillation
Primary: Incidence of Major Bleeding or Clinically Relevant Non-major Bleeding Events — 9.2; 6.4 No. of new events per 100 person-years
Sensorineural Hearing Loss
Primary: Safety: Treatment-Emergent Adverse Events (TEAE) — 13; 5 Participants
Chronic Asthma · COPD
Primary: Time to Next Asthma or COPD Exacerbation up to 182 Days — 172; 161 days to first exacerbation
Aneurysm, Brain
Primary: Efficacy: Adequate Occlusion — 366 Participants
Influenza · Seasonal Influenza
Primary: Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days of Product Administration — 4; 12; 9; 8 Participants
Spondylosis · Cervical Spondylosis · Spondylolisthesis
Primary: Fusion Rates Per Level Using the Bridwell Interbody Grading Scale — 64; 50 Fusions
Labor Induction · Early Amniotomy
Primary: Time to Active Phase of Labor — 885; 975 minutes